Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon

Oncogene

Volumn 23, Issue 49, 2004, Pages 8128-8134

  Poole, Aleksandra Jovanovic ^a   Heap, Darien ^a   Carroll, Robert E ^a   Tyner, Angela L ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Aberrant crypt foci; Azoxymethane; Colon; p21; Waf1

Indexed keywords

AZOXYMETHANE; CELL DNA; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ABERRANT CRYPT FOCUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL AGGREGATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DNA DAMAGE; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; INFLAMMATORY CELL; INTESTINE CRYPT; LYMPHOID CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; WILD TYPE; ANIMAL; COLON TUMOR; NICK END LABELING; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; RODENTIA;

ANIMALS; APOPTOSIS; AZOXYMETHANE; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; IN SITU NICK-END LABELING; MICE; PRECANCEROUS CONDITIONS;

EID: 7944234858     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207994     Document Type: Article

References (39)

1. Aizu W, Guda K, Nambiar P, Xin T, Thibodeau M, Rosenberg DW and Giardina C. (2003). Toxicol. Lett., 144, 213-224.
2. Balomenos D, Martin-Caballero J, Garcia MI, Prieto I, Flores JM, Serrano M and Martinez AC. (2000). Nat. Med., 6, 171-176.
3. Bird RP, McLellan EA and Bruce WR. (1989). Cancer Surv., 8, 189-200.
4. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. (1995). Nature, 377, 552-557.
5. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B. (1998). Science, 282, 1497-1501.
6. Carter JW, Lancaster HK, Hardman WE and Cameron IL. (1994). Cancer Res., 54, 4304-4307.
7. Cheng JD, Werness BA, Babb JS and Meropol NJ. (1999). Clin. Cancer Res., 5, 1057-1062.
8. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M and Scadden DT. (2000). Science, 287, 1804-1808.
9. Chinery R, Brockman J, Peeler MO, Shyr Y, Beauchamp RD and Coffey RJ. (1997). Nat. Med., 3, 1233-1241.
10. Deng C, Zhang P, Harper J, Elledge S and Leder P. (1995). Cell, 82, 675-684.
11. Evan GI and Vousden KH. (2001). Nature, 411, 342-348.
12. Feinberg A and Zedeck MS. (1980). Cancer Res., 40, 4446-4450.
13. Gartel AL, Serfas MS, Gartel M, Goufman E, Wu GS, El-Deiry WS and Tyner AL. (1996). Exp. Cell Res., 227, 171-181.
14. Gartel AL and Tyner AL. (1999). Exp. Cell Res., 246, 280-289.
15. Gartel AL and Tyner AL. (2002). Mol. Cancer Ther., 1, 639-649.
16. Goke R, Goke A, Goke B, El-Deiry WS and Chen Y. (2001). Digestion, 64; 75-80.
17. Hingorani R, Bi B, Dao T, Bae Y, Matsuzawa A and Crispe IN. (2000). J. Immunol., 164, 4032-4036.
18. Hirose Y, Yoshimi N, Makita H, Hara A, Tanaka T and Mori H. (1996). Jpn. J. Cancer Res., 87, 575-582.
19. Jackson RJ, Engelman RW, Coppola D, Cantor AB, Wharton W and Pledger WJ. (2003). Cancer Res., 63, 3021-3025.
20. Kadowaki Y, Fujiwara T, Fukazawa T, Shao J, Yasuda T, Itoshima T, Kagawa S, Hudson LG, Roth JA and Tanaka N. (1999). Clin. Cancer Res., 5, 4233-4241.
21. Kang KH, Kim WH and Choi KH. (1999). Exp. Cell Res., 253, 403-412.
22. Kwon, YH, Jovanovic A, Serfas MS, Kiyokawa H and Tyner AL. (2002). J. Biol. Chem., 277, 41417-41422.
23. Kwon YH, Jovanovic A, Serfas MS and Tyner AL. (2003). J. Biol. Chem., 278, 30348-30355.
24. Lincet H, Poulain L, Remy JS, Deslandes E, Duigou F, Gauduchon P and Staedel C. (2000). Cancer Lett., 161, 17-26.
25. Luo Y, Hurwitz J and Massague J. (1995). Nature, 375, 159-161.
26. Macleod K, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T. (1995). Genes Dev., 9, 935-944.
27. Martin-Caballero J, Flores JM, Garcia-Palencia P and Serrano M. (2001). Cancer Res., 61, 6234-6238.
28. Niculescu III AB, Chen X, Smeets M, Hengst L, Prives C and Reed SI. (1998). Mol. Cell. Biol., 18, 629-643.
29. Paulsen JE, Steffensen IL, Loberg EM, Husoy T, Namork E and Alexander J. (2001). Cancer Res., 61, 5010-5015.
30. Philipp J, Vo K, Gurley KE, Seidel K and Kemp CJ. (1999). Oncogene, 18, 4689-4698.
31. Potten CS, Li YQ, O'Connor PJ and Winton DJ. (1992). Carcinogenesis, 13, 2305-2312.
32. Rhodes JM and Campbell BJ. (2002). Trends Mol. Med., 8, 10-16.
33. Rothenberg ME, Mishra A, Brandt EB and Hogan SP. (2001). Immunol. Rev., 179, 139-155.
34. Sheikh MS, Rochefort H and Garcia M. (1995). Oncogene, 11, 1899-1905.
35. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H and Niitsu Y. (1998). N. Engl. J. Med., 339, 1277-1284.
36. Topley GI, Okuyama R, Gonzales JG, Conti C and Dotto GP. (1999). Proc. Natl. Acad Sci. USA, 96, 9089-9094.
37. Tsao YP, Huang SJ, Chang JL, Hsieh JT, Pong RC and Chen SL. (1999). J. Virol., 73, 4983-4990.
38. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R and Clevers H. (2002). Cell, 111, 241-250.
39. Yang J, Fan GH, Wadzinski BE, Sakurai H and Richmond A. (2001). J. Biol. Chem., 276, 47828-47833.